Insightec announced that the editorial panel of the American Medical Association approved their application to establish a new Category I Current Procedural Terminology code to facilitate reimbursement for MR-guided focused ultrasound ablation of neurological targets.
New code means acceptance of focused ultrasound technology as mainstream treatment, leading to standardized reimbursement for US physicians
HAIFA, Israel and MIAMI, Nov. 2, 2023 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that the editorial panel of the American Medical Association (AMA) approved their application to establish a new Category (Cat) I Current Procedural Terminology (CPT®) code to facilitate reimbursement for MR-guided focused ultrasound (MRgFUS) ablation of neurological targets. The Cat I CPT® code will be included in the next CPT® codebook and expected to be effective January 1, 2025.
“Achieving a Cat I CPT® code is a tremendous milestone for not only Insightec, but for patients and physicians across the United States,” explains Maurice R. Ferré, MD, CEO and chairman of the board of Insightec. “We’ve long known that focused ultrasound has a significant and valuable role in treating patients with neurological disorders. The approval of this code is further validation and indication of the broader adoption of focused ultrasound, and assurance that those who provide this critical service will receive consistent reimbursement.”
“This approval can also lead to expanded access to focused ultrasound for US patients,” says Dee Kolanek, vice president of market access and reimbursement for Insightec. “Thanks to the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) who supported the application, this code now gives physicians a definitive reimbursement and, we believe, will have a positive impact on both sales and utilization going forward.”
Focused ultrasound, which was pioneered by Insightec, is FDA approved to treat essential tremor and Parkinsonian tremor. The procedure is performed in a single, outpatient procedure with many patients showing immediate improvement of tremor in the treated hand with minimal or no complications. There are currently over 50 treatment centers across the United States and more than 125 treatment centers around the world using Insightec’s Exablate® Neuro platform.
About Insightec
Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company’s Exablate Neuro platform focuses sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson’s disease. Research for future applications in the neuroscience space is underway in partnership with leading academic and medical institutions. Insightec is headquartered in Haifa, Israel, and Miami, with offices in Dallas, Shanghai, and Tokyo.
Follow us on Facebook, LinkedIn and Twitter or visit www.insightec.com for more information.
Forward-looking Statements:
This document contains forward-looking statements regarding, among other things, plans, expectations, and future events. In some cases, forward-looking statements can be identified by the following words: “may,” “can,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “promise,” “continue,” “ongoing,” or the negative of these terms. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. Any forward-looking statement is based on information available to Insightec as of the date of the statement. All written or oral forward-looking statements attributable to Insightec are qualified by this caution. Insightec does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Insightec’s expectations.
“Exablate,” and “Exablate Neuro,” as well as the “INSIGHTEC” logo, whether standing alone or in connection with the word “Insightec”, are protected trademarks of Insightec.
Insightec Media Contact:
G&S Business Communications for Insightec
Marjani Williams
mwilliams@gscommunications.com
(312) 648-6700, ext.2108
Photo - https://mma.prnewswire.com/media/1699588/4172473/Insightec_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/insightec-announces-new-category-i-cpt-code-from-ama-for-neuro-procedures-using-mr-guided-focused-ultrasound-301975987.html
SOURCE INSIGHTEC
